Nasal tanning sprays: what a dermatologist's warning actually means
Quick answer
The video addresses melanotan II, a synthetic melanocortin receptor agonist sold in unregulated nasal spray form as a cosmetic tanning agent. Unlike endogenous alpha-MSH, MT-II is a cyclic, degradation-resistant analog with documented systemic activity across MC1R through MC5R, producing effects on appetite, sexual arousal, and potentially nevi behavior. The absence of FDA approval, standardized dosing, or manufacturing oversight makes these products a genuine clinical safety concern, not merely a regulatory technicality.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @joshzeichnermd actually say?
He said nasal tanning sprays are trending, urged viewers not to use them, and identified the active ingredient as a peptide that mimics a naturally occurring hormone. His core concern was simple: "we just don't know if they're safe." He flagged three specific risks: appetite changes, effects on sex drive, and the theoretical possibility of cancerous skin changes. He closed by recommending self-tanning creams as the only safe alternative.
This is a measured, cautious take from a board-certified dermatologist, and for the most part it holds up. He did not oversell the danger or manufacture certainty where none exists. But there are a few places where the framing deserves closer inspection, particularly around the cancer claim and what "mimics a hormone" actually means biologically.
Does the science back this up?
Mostly, yes. The peptide in question is almost certainly melanotan II (MT-II), a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), which binds melanocortin receptors (MC1R through MC5R) and drives melanogenesis. The off-label, unregulated nature of these products is a legitimate clinical concern backed by published literature.
The appetite and libido effects are real and documented. MC4R activation by MT-II suppresses appetite, while MC3R and MC4R signaling influences sexual arousal. A randomized controlled trial by Diamond et al. (2004, Annals of Internal Medicine) found that intracavernosal MT-II produced erections in men with psychogenic erectile dysfunction, confirming central receptor activity beyond just skin. Nausea, flushing, and spontaneous erections were the most commonly reported adverse effects in that study.
The cancer angle is where things get more speculative. Melanocyte stimulation does not directly cause melanoma. However, case reports have documented new or changing nevi following MT-II use, and a letter by Langan et al. (2011, British Journal of Dermatology) described a case of melanoma in a MT-II user. That is not proof of causation, but it is a legitimate signal worth naming.
What did they get wrong (or right)?
He got the core risk profile right. But the phrase "theoretically lead to cancerous changes" is doing a lot of work without enough scaffolding. Viewers may hear that as "this causes skin cancer," which the current evidence does not support. The honest read of the literature is that MT-II may accelerate growth in pre-existing atypical nevi rather than de novo cause malignancy. That distinction matters.
He also described MT-II as a peptide that "mimics a hormone naturally found in our bodies," which is accurate but incomplete. Alpha-MSH is naturally produced and breaks down quickly. MT-II is a modified, cyclic version engineered specifically to resist degradation and bind more aggressively. That is why it produces systemic effects at low doses. The word "mimic" understates the pharmacological difference.
What he got right: framing this as an unregulated, understudied compound with systemic receptor activity beyond skin. That is exactly the right warning to give a general audience on TikTok.
What should you actually know?
Melanotan II is not FDA-approved for any indication. It is not legally sold as a drug or cosmetic in the United States. Products sold as "tanning nasal sprays" are unregulated, meaning there is no quality control, no verified dosing, and no post-market safety surveillance. You genuinely do not know what you are putting in your body.
The systemic receptor profile is the real issue here. MT-II does not just hit your skin cells. It crosses into central nervous system activity, affecting appetite regulation, sexual function, and potentially cardiovascular tone. A review by Wikberg et al. (2000, Drug Discovery Today) mapped the full melanocortin receptor system and made clear that a compound hitting all five receptor subtypes is not a benign cosmetic agent.
If you are interested in peptide therapy for legitimate clinical indications, that conversation belongs with a licensed provider, not a nasal spray purchased from an unverified online vendor. Self-tanning creams using dihydroxyacetone (DHA) remain the only topically applied option with an actual safety record.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Nasal tanning sprays: what a dermatologist's warning actually means, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
SCENESSE (afamelanotide implant) FDA Prescribing Information
Afamelanotide (an alpha-MSH analog) is the only FDA-approved melanocortin peptide of this class, and only to increase pain-free light exposure in erythropoietic protoporphyria, not for cosmetic tanning.
FDA
Afamelanotide for Erythropoietic Protoporphyria
Randomized placebo-controlled trials (NEJM) behind the afamelanotide approval; this is the legitimate human melanocortin evidence, distinct from unapproved tanning peptides.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Nasal tanning sprays: what a dermatologist's warning actually means is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
The video addresses melanotan II, a synthetic melanocortin receptor agonist sold in unregulated nasal spray form as a cosmetic tanning agent.
FormBlends verdict
The video addresses melanotan II, a synthetic melanocortin receptor agonist sold in unregulated nasal spray form as a cosmetic tanning agent. Unlike endogenous alpha-MSH, MT-II is a cyclic, degradation-resistant analog with documented systemic activity across MC1R through MC5R, producing effects on appetite, sexual arousal, and potentially nevi behavior. The absence of FDA approval, standardized dosing, or manufacturing oversight makes these products a genuine clinical safety concern, not merely a regulatory technicality.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video addresses melanotan II, a synthetic melanocortin receptor agonist sold in unregulated nasal spray form as a cosmetic tanning agent. Unlike endogenous alpha-MSH, MT-II is a cyclic, degradation-resistant analog with documented systemic activity across MC1R through MC5R, producing effects on appetite, sexual arousal, and potentially nevi behavior. The absence of FDA approval, standardized dosing, or manufacturing oversight makes these products a genuine clinical safety concern, not merely a regulatory technicality.
- Melanotan II is not FDA-approved for any use and is not legally classified as a drug or cosmetic in the United States, meaning no manufacturing, dosing, or purity standards apply to products sold online.
- A 2004 RCT by Diamond et al. in Annals of Internal Medicine confirmed that MT-II produces significant systemic effects including erections, nausea, and flushing, confirming it acts well beyond skin pigmentation.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Melanotan II is not FDA-approved for any use and is not legally classified as a drug or cosmetic in the United States, meaning no manufacturing, dosing, or purity standards apply to products sold online.
- A 2004 RCT by Diamond et al. in Annals of Internal Medicine confirmed that MT-II produces significant systemic effects including erections, nausea, and flushing, confirming it acts well beyond skin pigmentation.
- MT-II binds all five melanocortin receptor subtypes (MC1R through MC5R), making it a systemically active compound with effects on appetite, cardiovascular tone, and sexual function, not a cosmetic agent.
- The cancer link is based on case reports and biological plausibility, not controlled trial evidence; Langan et al. (2011, BJD) documented a melanoma case in a user, but causation has not been established.
- Unlike endogenous alpha-MSH, MT-II is a cyclic peptide engineered to resist degradation, meaning its effects are more potent and longer-lasting than the natural hormone it resembles.
- Self-tanning creams using DHA have decades of safety data and regulatory review; they remain the only evidence-supported topical method for achieving tan appearance without UV or receptor-level intervention.
- Nasal delivery of peptides bypasses first-pass metabolism and can accelerate central nervous system exposure, which adds a layer of unpredictability to an already uncharacterized compound.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Skincare From A to Dr Z · TikTok creator
176.4K views on this video
Dermatologist gives nasal tanning sprays a thumbs down! #tanning #selftanner #tanningnasal #tanlines #skincaretiktok #dermatologist
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Skincare From A to Dr Z, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.